Literature DB >> 25593257

Complete genome sequence of a newcastle disease virus isolate from an outbreak in central India.

Polakshee Gogoi1, Sudhir Morla1, Megha Kaore2, Nitin Vasantrao Kurkure2, Sachin Kumar3.   

Abstract

The complete genome sequence of a Newcastle disease virus (NDV) strain NDV/Chicken/Nagpur/01/12 was isolated from vaccinated chicken farms in India during outbreaks in 2012. The genome is 15,192 nucleotides in length and is classified as genotype VII in class II.
Copyright © 2015 Gogoi et al.

Entities:  

Year:  2015        PMID: 25593257      PMCID: PMC4299899          DOI: 10.1128/genomeA.01418-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Newcastle disease virus (NDV) causes a highly pathogenic viral disease known as Newcastle disease (ND) in avian species. It is classified under avian paramyxovirus serotype 1 (APMV-1). NDV is a single-stranded, nonsegmented, negative sense RNA virus belonging to the genus Avulavirus, in the family Paramyxoviridae (1). The genome sizes of NDV strains isolated from different parts of the world are categorized into three different groups: the isolates before 1960 are 15,186 nucleotides (nt) long, the isolates reported from China are 15,192 nt long, and the isolates discovered in Germany are 15,198 nt long (2). Based on genetic analysis, strains of NDV are classified into classes I and II. Avirulent strains isolated from wild birds are classified under class I genotype, whereas both virulent and avirulent strains isolated from wild and domestic birds are classified under class II (3). In India, there have been continuous reports of ND outbreaks which have affected the economy of domestic poultry industries significantly despite various drives of vaccination programs (4, 5). For effective control of NDV, a greater understanding of NDV’s genetic diversity is necessary. In the year 2012, ND outbreaks were reported from chicken farms located in the Nagpur district of the state Maharashtra in India. The affected commercial chickens were vaccinated with NDV strain LaSota. The outbreak has caused nearly 100% mortality. The various pathognomonic signs and symptoms observed in the diseased chickens were pinpoint hemorrhages at the tips of the proventricular glands and cecal tonsil and button ulcers in the duodenum and large intestine. In addition, mild congestion of brain, liver, and in the bursa was also observed. The virus was isolated and propagated in 9-day-old embryonated chicken eggs. One of the isolates, namely, NDV/Chicken/Nagpur/01/12, was plaque purified in chicken embryo fibroblast and the complete genome sequence was determined by reverse transcription (RT)-PCR using overlapped consensus primers and direct sequencing (6). To determine the 3′ and 5′ ends of the viral genome, rapid amplification of cDNA ends (RACE) was used (7). The complete genome of NDV/Chicken/Nagpur/01/12 is 15,192 in length. The sequence identities of amino acids of fusion (F) and hemagglutinin-neuraminidase (HN) proteins between NDV strain NDV/Chicken/Nagpur/01/12 and the lentogenic vaccine strain LaSota are 88.4% and 85.3%, respectively. From the sequence analysis it has been found that the circulating strains of the outbreak are distinctly different from the vaccine strain. The sequence of the F protein cleavage site is the major determinant of the NDV pathogenicity. The strain NDV/Chicken/Nagpur/01/12 has a virulent pathotype, with 112RRQKR116 at the C terminus of the F2 protein and F at residue 117 (8). The phylogenetic analysis by MEGA 5.2 of the F gene suggests that the present isolate belongs to genotype VII of class II (9).

Nucleotide sequence accession number.

The complete genome sequence of NDV/Chicken/Nagpur/01/12 is deposited in GenBank under the accession no. KP089979.
  8 in total

1.  Complete genome sequence of avian paramyxovirus type 3 reveals an unusually long trailer region.

Authors:  Sachin Kumar; Baibaswata Nayak; Peter L Collins; Siba K Samal
Journal:  Virus Res       Date:  2008-08-15       Impact factor: 3.303

2.  Complete genome sequence of highly virulent neurotropic Newcastle disease virus strain Texas GB.

Authors:  Anandan Paldurai; Sachin Kumar; Baibaswata Nayak; Siba K Samal
Journal:  Virus Genes       Date:  2010-04-30       Impact factor: 2.332

3.  Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes.

Authors:  Diego G Diel; Luciana H A da Silva; Hualei Liu; Zhiliang Wang; Patti J Miller; Claudio L Afonso
Journal:  Infect Genet Evol       Date:  2012-08-07       Impact factor: 3.342

4.  Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications.

Authors:  Alíz Czeglédi; Dorina Ujvári; Eszter Somogyi; Eniko Wehmann; Ortrud Werner; Béla Lomniczi
Journal:  Virus Res       Date:  2006-09       Impact factor: 3.303

Review 5.  Newcastle disease: evolution of genotypes and the related diagnostic challenges.

Authors:  Patti J Miller; Eduardo Lucio Decanini; Claudio L Afonso
Journal:  Infect Genet Evol       Date:  2009-09-30       Impact factor: 3.342

6.  Complete genome sequence of a newcastle disease virus isolate from an outbreak in northern India.

Authors:  Sudhir Morla; Ashok Kumar Tiwari; Vinay Joshi; Sachin Kumar
Journal:  Genome Announc       Date:  2014-04-24

7.  Role of fusion protein cleavage site in the virulence of Newcastle disease virus.

Authors:  Aruna Panda; Zhuhui Huang; Subbiah Elankumaran; Daniel D Rockemann; Siba K Samal
Journal:  Microb Pathog       Date:  2004-01       Impact factor: 3.738

Review 8.  Newcastle disease virus: current status and our understanding.

Authors:  Ketan Ganar; Moushumee Das; Sugandha Sinha; Sachin Kumar
Journal:  Virus Res       Date:  2014-03-01       Impact factor: 3.303

  8 in total
  1 in total

1.  Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India.

Authors:  U Kumar; S Kumar
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.